Effect of plasma glucose at admission on COVID-19 mortality: experience from a tertiary hospital

Bharat Kumar1, Madhukar Mittal1, Maya Gopalakrishnan1

  • 1All India Institute of Medical Sciences, Jodhpur, Rajasthan, India.

Insights

Admission plasma glucose levels in hospitalized COVID-19 patients are a strong predictor of mortality. Higher glucose levels correlate with increased risk, especially in patients with diabetes mellitus.

Area of Science:

  • Infectious Diseases
  • Endocrinology
  • Critical Care Medicine

Background:

  • Plasma glucose levels are linked to mortality in various diseases, including infections.
  • Understanding glucose's role in COVID-19 is crucial for patient management.

Purpose of the Study:

  • To investigate the association between plasma glucose at admission and mortality in hospitalized COVID-19 patients in Jodhpur, India.
  • To explore the relationship between glucose levels, disease severity, and patient outcomes.

Main Methods:

  • A hospital-based clinical study involving 386 COVID-19 patients from May 15 to June 30, 2020.
  • Collected random blood samples for plasma glucose, interleukin-6 (IL6), and high-sensitivity C-reactive protein (hsCRP) assays.
  • Analyzed data to correlate glucose levels with mortality, disease severity, and inflammatory markers.

Main Results:

  • A total of 386 patients were studied; 4.1% expired. Patients with known diabetes mellitus had three times higher mortality.
  • Higher plasma glucose levels were observed in patients with moderate to severe COVID-19 and in non-survivors.
  • Plasma glucose strongly correlated with inflammatory markers (IL6 and hsCRP) and increased mortality risk with rising glucose levels.

Conclusions:

  • Plasma glucose at admission is a significant predictor of mortality in hospitalized COVID-19 patients.
  • Elevated glucose levels indicate a poorer prognosis and are associated with increased inflammation.
Abstract

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
503
Overview of Carbohydrate Metabolism01:19

Overview of Carbohydrate Metabolism

Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
2.4K
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
3.0K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.4K